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Background: Transradial approach has gained increasing popularity for elective percutaneous coronary intervention. However, safety and feasibility 
of transradial coronary intervention (TRI) in acute myocardial infarction (AMI) remains uncertain. Hence, a meta-analysis of randomized trials was 
performed to compare outcomes of TRI with transfemoral coronary intervention (TFI) in patients with AMI.
Methods: A systematic review of literature revealed 7 randomized trials involving 1306 patients. End points extracted were access site 
complications, major adverse cardiovascular events (MACE), major bleeding and procedural success. Combined relative risks (RR) across all studies 
and 95% confidence intervals (CI) were computed. A two-sided alpha error of <0.05 was considered to be statistically significant.
Results: Baseline characteristics were similar in both groups. Compared with patients undergoing TFI, risk of MACE (RR: 0.83, CI: 0.51-1.35; 
p=0.45) and major bleeding (RR: 0.51, CI: 0.20-1.26; p=0.14) was similar in patients having TRI. The procedural success was similar with both 
approaches (RR: 0.99, CI: 0.96-1.02; p=0.59). However, incidence of access site complications is significantly lower in TRI group (RR: 0.31, CI: 0.17-
0.52; p<0.001).
Conclusions: The meta-analysis suggests that TRI is superior to TFI in reducing access site complications in patients with 
AMI. However, there is no difference in procedural success or incidence of MACE and major bleeding between two groups.
